AC
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer | Science Advances |  | 2021 | 495 | 336 | ||
| Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients | Journal for immunotherapy of cancer | | 2020 | 580 | 299 | ||
| High-throughput screening of human tumor antigen-specific CD4 T cells, including neoantigen-reactive T cells | Clinical Cancer Research |  | 2019 | 447 | 4 | ||
| Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope | OncoImmunology | | 2016 | 347 | 1 | ||
| Vaccination with long NY-ESO-1 79-108 peptide and CpG-B leads to robust activation of CD4 and CD8 T cell responses in stage III/IV melanoma patients, and a new HLA-DR7 epitope | 30th Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2015) | | 2015 | 1 | 0 |
